Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 29 to Dec. 3, 2021. …
mRNA-1273, BNT162b2 Vaccines Comparable for Lowering COVID-19 Risk
mRNA-1273 marginally more effective than BNT162b2 among U.S. veterans, but risk for outcomes at 24 weeks low with both vaccines
SARS-CoV-2 Infection Up >90 Days Since Second BNT162b2 Dose
Individuals who tested positive for SARS-CoV-2 had significantly longer time elapsed since vaccine injection
Caregivers of Childhood Cancer Survivors Concerned About COVID-19 Vaccines
Concerns, expressed early in the rollout, included lack of safety and efficacy data, particularly in children with cancer
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 22 to 24, 2021. This …
As Vaccine Deadline Passes, 95 Percent of Federal Workers Have Gotten Shots
Only about 59 percent of the general population are fully vaccinated, according to CDC data
30 Percent of Hospital-Based Health Care Personnel Unvaccinated
COVID-19 vaccination coverage increased from 36.1 to 60.2 percent from January to April 2021, then slowed, reaching 70.0 percent as of Sept. 15
Pfizer Says Its COVID-19 Vaccine Provides Full Protection to Adolescents
Pfizer will submit these new data to the FDA as it seeks full approval of the vaccine for youth ages 12 to 15 years
Patients Hospitalized With COVID-19 Less Likely to Be Vaccinated
Decreased likelihood of vaccination also seen in association with death, mechanical ventilation among patients hospitalized with COVID-19
Access to Care Disrupted for Young Adults With Diabetes in COVID-19
Young adults with diabetes also report lower intention of receiving COVID-19 vaccination compared with those 60 years or older